文献速递外周血管胸部介入MR

自1984年起用于治疗肺动静脉畸形的原位金属弹簧圈和Amplatzer血管封堵器患者可安全接受磁共振成像

Patients with in-situ metallic coils and Amplatzer vascular plugs used to treat pulmonary arteriovenous malformations since 1984 can safely undergo magnetic resonance imaging.
PubMed 文献 · Br J Radiol · 2019-04-24

回顾性审计英国Hammersmith医院1984至2017年接受肺动静脉畸形栓塞治疗患者的MRI安全性,20例在本院行1.5 T MRI(涉及100枚钢圈、140枚MR条件兼容弹簧圈和54枚MRI条件兼容Amplatzer血管封堵器),另7例早期钢圈治疗患者在其他机构行MRI,均未报告不良事件,结论为1.5 T MRI安全。

要点

  • 肺动静脉畸形栓塞术后患者行1.5 T MRI未报告不良事件,包括使用最早钢圈(1984-1995年)的患者。
  • 本院20例患者涉及100枚钢圈(中位22年后)、140枚MR条件兼容弹簧圈(中位9.3年后)和54枚MRI条件兼容Amplatzer封堵器(中位0.75年后)。
  • 作者认为MRI可在不联系专科肺动静脉畸形治疗中心审批的情况下实施。

核心结论

  • 自1984年起在英国主要中心置入的所有肺动静脉畸形栓塞装置在1.5 T MRI下均显示安全性。

研究设计与样本

  • 回顾性审计,纳入1984至2017年伦敦Hammersmith医院所有接受肺动静脉畸形栓塞治疗的患者,记录本院所有MRI检查结局,并记录早期钢圈(1984-1995年)治疗患者中已知的所有MRI检查结局。

关键影像表现/征象

  • 本院20例患者置入100枚钢圈(15.5-28.6年,中位22年)后行1.5 T MRI,未报告不良事件。
  • 本院同组患者置入140枚MR条件兼容弹簧圈(0.42-12.7年,中位9.3年)和54枚MRI条件兼容Amplatzer血管封堵器(0.17-8.0年,中位0.75年)后行MRI,许多装置联合使用,未报告不良事件。
  • 多数扫描为脑部适应症,其他扫描部位包括脊柱、胸部和盆腔区域。
  • 另7例接受最早钢圈(1984-1995年)治疗的患者在其他机构已知行MRI,未报告不良事件,多数扫描为脑部适应症。

临床应用与阅片要点

  • 作者认为,对经栓塞治疗的肺动静脉畸形患者行MRI可不联系专科肺动静脉畸形治疗中心审批。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To examine the MRI safety of metallic coils and Amplatzer vascular plugs. Currently, concern regarding MR safety of devices used to treat pulmonary arteriovenous malformations (PAVMs) causes delays in performing emergency MRI in patients presenting with acute neurological symptoms.

METHODS: A retrospective audit was performed on all patients who underwent PAVM embolization at Hammersmith Hospital, London UK between 1984 and 2017. Outcomes of all MRI studies performed at our institution were recorded. In addition, known outcomes of all known MRI studies performed on patients treated with the earliest steel coils (1984-1995) were recorded.

RESULTS: At our institution, 20 patients underwent 1.5 T MRI after the insertion of 100 steel coils (15.5 - 28.6, median 22 years later), 140 coils designated MR-conditional (0.42 - 12.7, median 9.3 years later), and 54 MRI-conditional Amplatzer vascular plugs (0.17 - 8.0, median 0.75 years later), many in combination. The majority of scans were for cerebral indications, but other body regions scanned included spinal, thoracic, and pelvic regions. No adverse events were reported. Similarly, there were no adverse events in any MR scan known to have been performed in other institutions in seven further patients treated with the earliest steel coils (1984-1995). Again, the majority of scans were for cerebral indications.

CONCLUSION: The findings demonstrate MR safety at 1.5 T of all PAVM embolization devices inserted in a main UK centre since inception in 1984.

ADVANCES IN KNOWLEDGE: MRI of patients who have had PAVMs treated by embolization can be implemented without contacting specialist pulmonary arteriovenous malformation treatment centres for approval.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Alsafi A, Jackson JE, Fatania G, et al. Patients with in-situ metallic coils and Amplatzer vascular plugs used to treat pulmonary arteriovenous malformations since 1984 can safely undergo magnetic resonance imaging. Br J Radiol. 2019. PMID: 30894022. doi:10.1259/bjr.20180752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。